Top in hem/onc: Lung cancer screening, liquid biopsy

The U.S. Preventive Services Task Force has issued a draft recommendation that lowers the age to begin lung cancer screening in individuals with a history of smoking. It was the top story in hematology/oncology last week.

Another top story is about a study that suggests a liquid biopsy could play a valuable role in guiding treatment of the most common form of pancreatic cancer.

Read these and more top stories in hematology/oncology below:

Draft USPSTF guidance lowers recommended age to start lung cancer screening

Individuals with a smoking history should begin annual screening for lung cancer at age 50 years instead of age 55 years, according to a draft recommendation issued by the U.S. Preventive Services Task Force. Read more.

Liquid biopsy shows promise for early detection of pancreatic cancer

A liquid biopsy has shown promise for the early detection and staging of pancreatic ductal adenocarcinoma. Read more.

American Cancer Society recommends routine HPV vaccination starting at age 9 years

Health care providers should begin offering routine HPV vaccination to children as young as age 9 years in order to increase rates of on-time administration, according to an updated American Cancer Society guideline. Read more.

ASCO develops guideline for management of men with breast cancer

Research has led to major improvements in breast cancer diagnosis, treatment and survival. However, men with breast cancer represent only 1% of the U.S. breast cancer population and have not been emphasized in this research. Read more.

Emergency surgery linked to higher risk for venous thromboembolism

Trauma patients who underwent emergency general surgery appeared to have a twofold higher risk for venous thromboembolism than patients who underwent elective surgery, according to study results published in JAMA Surgery. Read more.